MAPK Signaling

Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
B6674 AnisomycinTarget: p38|JNK|SAPKSummary: JNK agonist, potent and specific -
B5496 AMG 548Summary: P38α inhibitor,potent and selective -
A3805 SCH7729847 CitationSummary: ERK1 and ERK2 inhibitor -
A8313 RAF265Target: Raf|VEGFRSummary: Multiple intracellular kinases inhibitor -
B4937 SB 706504Summary: p38 MAPK inhibitor -
B5960 PF-03394197(Oclacitinib)Summary: Novel Janus kinase inhibitor -
A3594 MEK inhibitorSummary: Potent MEK inhibitor, Antitumor agent -
A8245 Sorafenib Tosylate1 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor -
B5942 AS601245Summary: c-Jun NH2-terminal protein kinase inhibitor -
B4620 Losmapimod1 CitationSummary: p38 MAPK inhibitor, orally active
